The Use of Bedaquiline in the Treatment of Multi-Drug Resistant Tuberculosis: Interim Policy Guidance

The Use of Bedaquiline in the Treatment of Multi-Drug Resistant Tuberculosis: Interim Policy Guidance

Author: World Health Organization, Global TB Programme
Publication Date: 2013
Format: Guideline
Language: English
How to Access this Material:
HTML: http://www.who.int/tb/challenges/mdr/bedaquiline/en/

Abstract

This interim guidance provides advice on the inclusion of bedaquiline in the combination therapy of MDR-TB in accordance with the existing WHO Guidelines for the Programmatic Management of Drug-resistant TB (2011 Update).

Publisher:

World Health Organization

Audience(s):

Health Professionals

Topic:

MDR TB, TB Treatment, Treatment- Medication Information

Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.